Acetaminophen Quantification via Quinoline Sulfonate Coupling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for quantitatively determining acetaminophen levels in samples face challenges such as toxicity, limited stability, and interference with other biomolecules, particularly in small sample volumes, leading to unreliable measurements and interactions with N-acetylcysteine and hemoglobin.

Innovation Solution

A method involving the hydrolysis of acetaminophen to form p-aminophenol, which reacts with a compound of general formula (III) containing a negatively charged sulfonate group in the presence of an oxidant to form a compound of general formula (IV), allowing for photometric determination, using reagents with reduced toxicity and improved solubility, enabling precise measurement with minimal sample volume.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If phenols (cresol or xylenol) are used for oxidative coupling to form indophenol, then acetaminophen can be determined quantitatively, but the phenols are toxic and have limited stability which impairs measurement reliability

Engineering Contradiction:
Improvemeasurement reliabilityVSAvoidtoxicity and stability of phenols
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical parameters of the coupling agent by replacing phenolic compounds with quinoline-based compounds featuring sulfonate groups. This substitution fundamentally alters the chemical properties: the new coupling agents exhibit reduced toxicity, improved stability, and enhanced water solubility while maintaining the ability to form colored indole dyes with p-aminophenol for acetaminophen quantification.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs coupling agents with improved stability characteristics that do not require the same level of careful handling and immediate use as the phenolic compounds. The quinoline-based coupling agents with sulfonate groups provide a more robust reagent system that can be stored and used with greater reliability, reducing the impact of reagent degradation on measurement accuracy.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Ease of operation

If enzyme-based assays are used for simplicity and economy, then acetaminophen determination is easier, but interactions and spectral/chemical interferences with other biomolecules lead to incorrect indications

Engineering Contradiction:
Improvesimplicity and economy of assayVSAvoidaccuracy affected by interferences
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent enhances the specificity of the reaction system by introducing coupling agents with particular chemical characteristics (quinoline scaffold with sulfonate groups). These localized chemical features enable selective reaction with p-aminophenol while resisting interference from other biomolecules present in the sample, thus maintaining simplicity without sacrificing accuracy.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The coupling agent acts as a specific intermediary that mediates between the hydrolyzed acetaminophen (p-aminophenol) and the detection system. The quinoline-based compound with sulfonate groups facilitates the formation of a colored indole dye product that can be measured spectrophotometrically, while its specific chemical structure prevents unwanted interactions with other sample components.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Quantity of substance

If known coupling agents are used for acetaminophen determination, then the method is established, but they do not address interactions with N-acetylcysteine and hemoglobin, and require relatively large sample volumes

Engineering Contradiction:
Improvesample volume requiredVSAvoidinteractions with NAC and hemoglobin
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent modifies the chemical parameters of the coupling agent to include a quinoline scaffold with sulfonate groups, which fundamentally changes the reaction characteristics. This structural modification reduces the required sample volume and minimizes interactions with interfering substances like N-acetylcysteine and hemoglobin, enabling accurate measurement in small pediatric samples.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The improved coupling agents enable the use of smaller sample volumes, which is particularly beneficial for pediatric patients where only small blood samples can be obtained. The enhanced sensitivity and reduced interference mean that accurate measurements can be achieved with minimal sample input.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method achieves high precision and sensitivity with reduced spectral and chemical interferences, allowing for accurate acetaminophen quantification in small sample volumes, particularly in pediatric samples, with improved stability and reduced radiation interferences.

Implementation Method 1

hydrolyzing acetaminophen with formula (I) and reacting the resulting p-aminophenol

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

reacting the resulting p-aminophenol with formula (II) with a compound of general formula (III) in the presence of an oxidant to form a compound of general formula (IV)

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 3

the amount of the compound of general formula (IV) in the reaction mixture is photometrically determined

Methodology Applied
Scientific EffectPhotometric determination: Absorption Spectroscopy

Data Source

PatentUS12012630B2Quantitative acetaminophen analytics
Publication Date: 2024.06.18 DIASYS DIAGNOSTIC SYST
  • US12012630B2 patent drawing
  • US12012630B2 patent drawing
  • US12012630B2 patent drawing

AI summary

A method for quantitatively determining the amount of acetaminophen in a sample with greater precision, greater sensitivity and fewer interactions and fewer spectral and chemical interferences with other compounds contained in the sample. The method includes acetaminophen being hydrolyzed and the resulting p-aminophenol being reacted with a compound of general formula (III):in the presence of an oxidant to form a compound of general formula (IV):wherein R1 and R2, independently of one another, are selected from H, —CH3, and —OCH3, R3 is —C2H5 and R4 is a C1-4 alkyl moiety with a terminal sulfonate group, with the proviso that at least one of R1 and R2 is —OCH3 and/or R4 additionally has at least one OH substituent, and then the amount of the compound of general formula (IV) in the reaction mixture being photometrically determined.